Report cover image

Generative AI Cybersecurity Market Size, Share, Trends, Industry Analysis Report By Type (Threat Detection & Analysis, Adversarial Defense), By Technology, By End Use, By Region – Market Forecast, 2025–2034

Published Sep 01, 2025
Length 126 Pages
SKU # PLRS20451525

Description

The generative AI cybersecurity market size is expected to reach USD 62.33 billion by 2034, according to a new study by Polaris Market Research. The report “Generative AI Cybersecurity Market Share, Size, Trends, Industry Analysis Report By Type (Threat Detection & Analysis, Adversarial Defense), By Technology, By End Use, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Generative AI cybersecurity can be defined as the use of AI-driven generative models to build adaptive, predictive, and automated defenses against evolving digital threats. This market is driven by the growing integration of generative AI with proactive threat intelligence systems, enabling security frameworks to predict potential attack vectors before they materialize. Generative AI enables organizations to stay ahead of malicious actors by imitating complex attack scenarios and creating adaptive defense strategies. This proactive capability shifts cybersecurity from a reactive posture to a ready one, improving resilience and reducing vulnerabilities across increasingly dynamic digital environments.

The generative AI cybersecurity market is driven by the increasing focus on autonomous security operations, where AI models are leveraged to automate detection, analysis, and response. This approach reduces reliance on human intervention, thereby addressing challenges such as talent shortages and the overwhelming volume of security alerts. Generative AI strengthens security workflows by learning from past incidents, continuously improving its ability to recognize anomalies, and autonomously mitigating risks. This growing trend highlights the transition toward intelligent, self-learning systems that not only protect digital infrastructures but also optimize operational efficiency in managing cybersecurity threats.

Generative AI Cybersecurity Market Report Highlights

In terms of type, the threat detection & analysis segment led the market in 2024, as its proactive role in identifying zero-day threats and sophisticated attacks is indispensable for modern security operations.

Based on technology, the reinforcement learning segment is anticipated to grow the fastest during the forecast period, fueled by its unique ability to autonomously adapt to constantly evolving cyberattack strategies.

North America held the largest share in 2024, due to its mature digital infrastructure, early AI adoption, and significant enterprise cybersecurity spending.

The Asia Pacific market is expected to grow the fastest, driven by rapid digital transformation, increasing internet access, and a surge in cyber threats.

A few key players in the generative AI cybersecurity market include Cohesity, Inc.; CrowdStrike; Darktrace Holdings Limited; Google; IBM; Lakera Inc; Microsoft; Palo Alto Networks; SentinelOne; Musarubra US LLC (Trellix); and Zscaler, Inc.

Polaris Market Research has segmented the generative AI cybersecurity market report on the basis of type, technology, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

Threat Detection & Analysis

Adversarial Defense

Insider Threat Detection

Network Security

Others

By Technology Outlook (Revenue, USD Billion, 2020–2034)

Generative Adversarial Networks (GANs)

Variational Auto encoders (VAEs)

Reinforcement Learning (RL)

Deep Neural Networks (DNNs)

Natural Language Processing (NLP)

Others

By End Use (Revenue, USD Billion, 2020–2034)

Banking, Financial Services, And Insurance (BFSI)

Healthcare & Life Sciences

Government & Defense

Retail and E-Commerce

Manufacturing & Industrial

IT & Telecommunications

Energy & Utilities

Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

126 Pages
Chapter 1.Introduction
1.1Report Description
1.1.1Objectives of the Study
1.1.2Market Scope
1.1.3Assumptions
1.2Stakeholders
Chapter 2.Executive Summary
Chapter 3.Research Methodology
3.1Overview
3.1.1Data Mining
3.2Data Sources
3.2.1Primary Sources
3.2.2Secondary Sources
Chapter 4.Europe CRISPR & Cas Genes Market Insights
4.1CRISPR & Cas Genes – Industry snapshot
4.1Europe CRISPR & Cas Genes Market Dynamics
4.1.1Drivers and Opportunities
4.1.1.1Innovations in CRISPR technologies
4.1.1.2Applicability in varied areas
4.1.2Restraints and Challenges
4.1.2.1Inherent Disadvantages
4.2Porter’s Five Forces Analysis
4.2.1Bargaining Power of Suppliers (Moderate)
4.2.2Threats of New Entrants: (Low)
4.2.3Bargaining Power of Buyers (Low to Medium)
4.2.4Threat of Substitute (Low)
4.2.5Rivalry among existing firms (Medium to High)
4.3PEST Analysis
4.4Europe CRISPR & Cas Genes Market Industry trends
4.5COVID-19 Impact Analysis
Chapter 5.Contact Point Information
5.1Contact Point Information for obtaining a license to use the technology
5.1.1Wellcome Trust Sanger Institute, Cambridge, UK
5.1.2The Innovative Genomics Initiative, California
5.1.3Thermo Fisher Scientific, Waltham, Massachusetts
5.1.4the Broad Institute and Whitehead Institute
5.1.5ERS Genomics Ltd
5.1.6Merck KGaA
5.1.7Oxford Genetics Limited
5.1.8Caribou Biosciences, Inc.
5.1.9CRISPR Therapeutics
5.1.10Sherlock Biosciences
5.1.11UC Berkeley
5.2The contract amount for genome editing technology
Chapter 6.Europe CRISPR & Cas Genes Market Assessment by Product & Services
6.1Introduction
6.2Product
6.2.1Kits & Enzymes
6.2.1.1Vector-based Cas
6.2.1.2DNA-free Cas
6.2.2Libraries
6.2.3Design Tool
6.2.5Other Products
6.3Services
6.3.1Cell Line Engineering
6.3.2gRNA Design
6.3.3Microbial Gene Editing
6.3.4DNA Synthesis
Chapter 7.Europe CRISPR & Cas Genes Market Assessment by Application
7.1Introduction
7.2Biomedical
7.3Agricultural
Chapter 8.Europe CRISPR & Cas Genes Market Assessment by End-Use
8.1Introduction
8.2Biotechnology & Pharmaceutical Companies
8.3Academics & Government Research Institutes
8.4Contract Research Organizations (CROs)
Chapter 9.Europe CRISPR & Cas Genes Market Assessment by Country
9.1Introduction
9.2Europe CRISPR & Cas Genes Market – Europe
9.2.1Europe CRISPR & Cas Genes Market – Germany
9.2.2Europe CRISPR & Cas Genes Market – UK
9.2.3Europe CRISPR & Cas Genes Market – France
9.2.4Europe CRISPR & Cas Genes Market – Italy
9.2.5Europe CRISPR & Cas Genes Market – Spain
9.2.6Europe CRISPR & Cas Genes Market – Netherlands
9.2.7Europe CRISPR & Cas Genes Market – Austria
Chapter 10.Competitive Landscape
10.1Product Launch & Collaborations Both Are The Best Adopted Strategies by the Companies
10.2Product Launch
10.3Partnerships/Collaborations/Agreements/Exhibitions
Chapter 11.The Company Profiles
11.1Addgene
11.1.1Business Overview
11.1.2Financial Snapshot
11.1.3Products and Services
11.2AstraZeneca
11.2.1Business Overview
11.2.2Financial Snapshot
11.2.3Products and Services
11.2.4Recent Developments
11.3Caribou Biosciences, Inc.
11.3.1Business Overview
11.3.2Financial Snapshot
11.3.3Products and Services
11.3.4Recent Developments
11.4Cellectis
11.4.1Business Overview
11.4.2Financial Snapshot
11.4.3Products and Services
11.4.4Recent Developments
11.5CRISPR Therapeutics
11.5.1Business Overview
11.5.2Financial Snapshot
11.5.3Products and Services
11.5.4Recent Developments
11.6Danaher Corporation
11.6.1Business Overview
11.6.2Financial Snapshot
11.6.3Products and Services
11.6.4Recent Developments
11.7Editas Medicine, Inc.
11.7.1Business Overview
11.7.2Financial Snapshot
11.7.3Products and Services
11.8Horizon Discovery Group Plc
11.8.1Business Overview
11.8.2Financial Snapshot
11.8.3Products and Services
11.8.4Recent Developments
11.9Mammoth Biosciences
11.9.1Business Overview
11.9.2Financial Snapshot
11.9.3Products and Services
11.10New England BioLabs
11.10.1Business Overview
11.10.2Financial Snapshot
11.10.3Products and Services
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.